An interferon signature in the peripheral blood of dermatomyositis patients is associated with disease activity

Molecular Medicine

Volumn 13, Issue 1-2, 2007, Pages 59-68

  Baechler, Emily C ^a   Bauer, Jason W ^a   Slattery, Catherine A ^a   Ortmann, Ward A ^a   Espe, Karl J ^a   Novitzke, Jill ^a   Ytterberg, Steven R ^b   Gregersen, Peter K ^c   Behrens, Timothy W ^a,d   Reed, Ann M ^b  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b MAYO CLINIC   (United States)

^c FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH   (United States)

^d GENENTECH INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON;

ADULT; ARTICLE; BLOOD; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; DERMATOMYOSITIS; DISEASE ACTIVITY; DISEASE ASSOCIATION; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMAN; HUMAN CELL; HUMAN TISSUE; JUVENILE; MALE; MITOCHONDRION; OXIDATIVE PHOSPHORYLATION; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGED; BIOLOGICAL MARKERS; BLOOD PROTEINS; CASE-CONTROL STUDIES; CLUSTER ANALYSIS; DERMATOMYOSITIS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; INTERFERON TYPE I; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS;

EID: 34248998426     PISSN: 10761551     EISSN: None     Source Type: Journal    
DOI: 10.2119/2006-00085.Baechler     Document Type: Article

References (46)

1. Mastaglia FL, Phillips BA. (2002) Idiopathic inflammatory myopathies: epidemiology, classification, and diagnostic criteria. Rheum. Dis. Clin. North. Am. 28:723-41.
2. Reed AM. (2001) Myositis in children. Curr. Opin. Rheumatol. 13:428-33.
3. O'Hanlon TP et al. (2005) Immunogenetic risk and protective factors for the idiopathic inflammatory myopathies: distinct HLA-A, -B, -Cw, -DRB1 and -DQA1 allelic profiles and motifs define clinicopathologic groups in Caucasians. Medicine (Baltimore). 84:338-49.
4. Christensen ML, Pachman LM, Schneiderman R, Patel DC, Friedman JM. (1986) Prevalence of Cox-sackie B virus antibodies in patients with juvenile dermatomyositis. Arthritis Rheum. 29:1365-70.
5. Greenberg SA et al. (2005) Interferon-alpha/beta-mediated innate immune mechanisms in dermatomyositis. Ann. Neurol. 57:664-78.
6. Greenberg SA et al. (2002) Molecular profiles of inflammatory myopathies. Neurology. 59:1170-82.
7. Raju R, Dalakas MC. (2005) Gene expression profile in the muscles of patients with inflammatory myopathies: effect of therapy with IVIg and biological validation of clinically relevant genes. Brain. 128:1887-96.
8. Tezak Z et al. (2002) Gene expression profiling in DQA1*0501+ children with untreated dermatomyositis: a novel model of pathogenesis. J. Immunol. 168:4154-63.
9. Zhou X, Dimachkie MM, Xiong M, Tan FK, Arnett FC. (2004) cDNA microarrays reveal distinct gene expression clusters in idiopathic inflammatory myopathies. Med. Sci. Monit. 10:BR191-7.
10. Baechler EC, Gregersen PK, Behrens TW. (2004) The emerging role of interferon in human systemic lupus erythematosus. Curr. Opin. Immunol. 16:801-7.
11. Ronnblom L, Eloranta ML, Alm GV. (2006) The type I interferon system in systemic lupus erythematosus. Arthritis Rheum. 54:408-20.
12. Baechler EC et al. (2003) Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus. Proc. Natl. Acad. Sci. U. S. A. 100:2610-5.
13. Bennett L et al. (2003) Interferon and granulopoiesis signatures in systemic lupus erythematosus blood. J. Exp. Med. 197:711-23.
14. Crow MK, Kirou KA, Wohlgemuth J. (2003) Microarray analysis of interferon-regulated genes in SLE. Autoimmunity. 36:481-90.
15. Dall'era MC, Cardarelli PM, Preston BT, Witte A, Davis JC Jr. (2005) Type I interferon correlates with serological and clinical manifestations of SLE. Ann. Rheum. Dis. 64:1692-7.
16. Kirou KA et al. (2005) Activation of the interferon-alpha pathway identifies a subgroup of systemic lupus erythematosus patients with distinct serologic features and active disease. Arthritis Rheum. 52:1491-503.
17. Peterson KS et al. (2004) Characterization of heterogeneity in the molecular pathogenesis of lupus nephritis from transcriptional profiles of laser-captured glomeruli. J. Clin. Invest. 113:1722-33.
18. Farkas L, Beiske K, Lund-Johansen F, Brandtzaeg P, Jahnsen FL. (2001) Plasmacytoid dendritic cells (natural interferon- alpha/beta-producing cells) accumulate in cutaneous lupus erythematosus lesions. Am. J. Pathol. 159:237-43.
19. Blomberg S et al. (2001) Presence of cutaneous interferon-alpha producing cells in patients with systemic lupus erythematosus. Lupus. 10:484-90.
20. Baechler EC et al. (2006) Gene expression profiling in human autoimmunity. Immunol. Rev. 210:120-37.
21. Bohan A, Peter JB. (1975) Polymyositis and dermatomyositis (first of two parts). N. Engl. J. Med. 292:344-7.
22. Bohan A, Peter JB. (1975) Polymyositis and dermatomyositis (second of two parts). N. Engl. J. Med. 292:403-7.
23. Huber AM et al. (2004) Validation and clinical significance of the Childhood Myositis Assessment Scale for assessment of muscle function in the juvenile idiopathic inflammatory myopathies. Arthritis Rheum. 50:1595-603.
24. Oddis CV et al. (2005) International consensus guidelines for trials of therapies in the idiopathic inflammatory myopathies. Arthritis Rheum. 52:2607-15.
25. Petri M, Genovese M, Engle E, Hochberg M. (1991) Definition, incidence, and clinical description of flare in systemic lupus erythematosus. A prospective cohort study. Arthritis. Rheum. 34:937-44.
26. Hochberg Y, Benjamini Y. (1990) More powerful procedures for multiple significance testing. Stat. Med. 9:811-8.
27. Tusher V, Tibshirani R, Chu G. (2001) Significance analysis of microarrays applied to the ionizing radiation response. Proc. Natl. Acad. Sci. U. S. A. 98:5116-21.
28. Eisen MB, Spellman PT, Brown PO, Botstein D. (1998) Cluster analysis and display of genome-wide expression patterns. Proc. Natl. Acad. Sci. U. S. A. 95:14863-8.
29. Batliwalla FM et al. (2005) Microarray analyses of peripheral blood cells identifies unique gene expression signature in psoriatic arthritis. Mol. Med. 11:21-9.
30. Semprini S et al. (2002) Evidence for differential S100 gene over-expression in psoriatic patients from genetically heterogeneous pedigrees. Hum. Genet. 111:310-3.
31. Batliwalla FM et al. (2005) Peripheral blood gene expression profiling in rheumatoid arthritis. Genes Immun. 6:388-97.
32. Schulze zur Wiesch A et al. (2004) Myeloid related proteins MRP8/MRP14 may predict disease flares in juvenile idiopathic arthritis. Clin. Exp. Rheumatol. 22:368-73.
33. Bouma G, Lam-Tse WK, Wierenga-Wolf AF, Drexhage HA, Versnel MA. (2004) Increased serum levels of MRP-8/14 in type 1 diabetes induce an increased expression of CD11b and an enhanced adhesion of circulating monocytes to fibronectin. Diabetes. 53:1979-86.
34. Kalled SL. (2005) The role of BAFF in immune function and implications for autoimmunity. Immunol. Rev. 204:43-54.
35. Nelson GW et al. (2004) Cutting edge: heterozygote advantage in autoimmune disease: hierarchy of protection/susceptibility conferred by HLA and killer Ig-like receptor combinations in psoriatic arthritis. J. Immunol. 173:4273-6.
36. van der Slik AR et al. (2003) KIR in type 1 diabetes: disparate distribution of activating and inhibitory natural killer cell receptors in patients versus HLA-matched control subjects. Diabetes. 52:2639-42.
37. Massa M et al. (2002) Self epitopes shared between human skeletal myosin and Streptococcus pyogenes M5 protein are targets of immune responses in active juvenile dermatomyositis. Arthritis Rheum. 46:3015-25.
38. Tews DS, Goebel HH. (1998) Cell death and oxidative damage in inflammatory myopathies. Clin. Immunol. Immunopathol. 87:240-7.
39. Perl A, Gergely P Jr., Nagy G, Koncz A, Banki K. (2004) Mitochondrial hyperpolarization: a checkpoint of T-cell life, death and autoimmunity. Trends Immunol. 25: 360-7.
40. Diebold SS, Kaisho T, Hemmi H, Akira S, Reis e Sousa C. (2004) Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA. Science. 303:1529-31.
41. Heil F et al. (2004) Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8. Science. 303:1526-9.
42. Hemmi H et al. (2000) A Toll-like receptor recognizes bacterial DNA. Nature. 408:740-5.
43. Bave U, Alm GV, Ronnblom L. (2000) The combination of apoptotic U937 cells and lupus IgG is a potent IFN-alpha inducer. J. Immunol. 165:3519-26.
44. Lovgren T, Eloranta ML, Bave U, Alm GV, Ronnblom L. (2004) Induction of interferon-alpha production in plasmacytoid dendritic cells by immune complexes containing nucleic acid released by necrotic or late apoptotic cells and lupus IgG. Arthritis. Rheum. 50:1861-72.
45. Graham R et al. (2006) A common haplotype of interferon regulatory factor 5 (IRF5) regulates splicing and expression and is associated with increased risk of systemic lupus erythematosus. Nat. Genet. 38:550-5.
46. Sigurdsson S et al. (2005) Polymorphisms in the tyrosine kinase 2 and interferon regulatory factor 5 genes are associated with systemic lupus erythematosus. Am. J. Hum. Genet. 76:528-37.